Columbus Children’s Foundation, a non-profit organization with a mission to bring gene therapeutics to children with ultra-rare genetic diseases, has received an in-kind donation from Viralgen, an AAV gene therapy GMP manufacturer. The donation provides significant capacity for validating and manufacturing adeno-associated virus (AAV) gene therapies to ensure that an underserved population of children who suffer from ultra-rare genetic disorders will receive what are often life-saving trea...